NorthWest Biotherapeutics Inc (NWBO)

[trocprofit]

I believe we will get a substantial update at ASCO. If not topline, we could get several data items that confirm the direction and efficacy if sustained through unblinding. Number alive, maybe a refresh from final collection but short of topline? Possibly information on SAP submissions and/or approval. Either way I do not believe that LP would present anything if it was not positive and significant. If she simply gives a repeat of SNO or no new information she wouldn't be going. I happen to be one of those who believe the unblinded, separated data will be even more impressive.